 Relevance focal cerebral ischemia models Experience fibrinolytic agents limitations individual ischemia models experience fibrinolytic agents early intervention rt-PA rapid thrombolysis functional recovery decreased mortality small animal stroke thromboembolism models rt-PA general effect clinical recovery MCA occlusion reperfusion nonhuman primate dose rates capable high rt-PA levels u-PA salutary effect intravenous infusion rt-PA u-PA early ischemia/infarction several model systems significant intracerebral hemorrhage true clinical relevance general impressions completion human studies studies well-conceived models vascular consequences reperfusion achievable thrombolytic agents